Berlin Institute of Health at Charité (BIH)

Highlights

Events

Federal Minister of Research Dorothee Bär at the GeneNovate Investors' Day

Biotechnology is considered one of the key technologies of Germany’s High-Tech Agenda and is expected to drive the development of tomorrow’s medicine. In an interview conducted on the occasion of the GeneNovate® Investors’ Day on June 9, Minister Dorothee Bär discusses, among other things, the importance of gene and cell therapies.

To the interview (in German)

Our Research groups

Capital of female scientists

Get to know women scientists who have had or continue to have a significant impact on teaching, research and our city. More than a hundred years after the first female student was officially enrolled, Berlin can now present itself as the capital of women scientists with the highest proportion of women professors in Germany.

Mehr erfahren

BIH Newsletter

You would like to receive the latest information from the Berlin Institute of Health (BIH)? Then subscribe to our newsletter and receive regular updates on our success stories in research and translation.

Confirm